{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:20:46Z","timestamp":1790299246529,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sleep Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.sleep.2021.05.036","type":"journal-article","created":{"date-parts":[[2021,6,20]],"date-time":"2021-06-20T06:05:54Z","timestamp":1624169154000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2351-0460","authenticated-orcid":false,"given":"Hyoeun","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6127-1045","authenticated-orcid":false,"given":"Yong Won","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7124-0736","authenticated-orcid":false,"given":"Keun Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4526-7967","authenticated-orcid":false,"given":"Christopher J.","family":"Earley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sleep.2021.05.036_bib1","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/j.sleep.2014.05.009","article-title":"Altered brain iron homeostasis and dopaminergic function in restless legs syndrome (Willis\u2013Ekbom disease)","volume":"15","author":"Earley","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib2","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/ajh.23397","article-title":"The prevalence and impact of restless legs syndrome on patients with iron deficiency anemia","volume":"88","author":"Allen","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.sleep.2021.05.036_bib3","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1001\/archinte.165.11.1286","article-title":"Restless legs syndrome prevalence and impact: REST general population study","volume":"165","author":"Allen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib4","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.sleep.2014.08.012","article-title":"Response to intravenous iron in patients with iron deficiency anemia (IDA) and restless leg syndrome (Willis\u2013Ekbom disease)","volume":"15","author":"Mehmood","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.sleep.2017.11.1126","article-title":"Evidence-based and consensus clinical practice guidelines for the iron treatment of restless legs syndrome\/Willis-Ekbom disease in adults and children: an IRLSSG task force report","volume":"41","author":"Allen","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib6","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.sleep.2011.06.009","article-title":"Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial","volume":"12","author":"Allen","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib7","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.sleep.2016.06.021","article-title":"Clinical efficacy of ferric carboxymaltose treatment in patients with restless legs syndrome","volume":"25","author":"Cho","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib8","first-page":"494","article-title":"The reliability and validity of the Korean version of paradigm of questions for epidemiology studies of restless legs syndrome and the Johns Hopkins telephone diagnostic interview form for the restless legs syndrome","volume":"25","author":"Cho","year":"2007","journal-title":"J\u00a0Korean Neurolog Assoc"},{"key":"10.1016\/j.sleep.2021.05.036_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S1389-9457(03)00010-8","article-title":"Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health","volume":"4","author":"Allen","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1389-9457(02)00258-7","article-title":"Validation of the international restless legs syndrome study group rating scale for restless legs syndrome","volume":"4","author":"Group","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.sleep.2017.11.1134","article-title":"Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome","volume":"42","author":"Cho","year":"2018","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/mdc3.12088","article-title":"Review of severity rating scales for restless legs syndrome: critique and recommendations","volume":"1","author":"Walters","year":"2014","journal-title":"Movement Disorders Clin Practice"},{"key":"10.1016\/j.sleep.2021.05.036_bib13","first-page":"263","article-title":"The reliability and validity of the Korean versions of the international restless legs scale and the restless legs syndrome quality of life questionnaire","volume":"28","author":"Yang","year":"2010","journal-title":"J\u00a0Korean Neurolog Assoc"},{"key":"10.1016\/j.sleep.2021.05.036_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1524-4733.2005.03010.x","article-title":"Validation of the restless legs syndrome quality of life questionnaire","volume":"8","author":"Abetz","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.sleep.2021.05.036_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1620\/tjem.203.189","article-title":"Development of the Korean version of Short-Form 36-Item Health Survey: health related QOL of healthy elderly people and elderly patients in Korea","volume":"203","author":"Han","year":"2004","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib16","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11325-011-0579-9","article-title":"The reliability and validity of the Korean version of the pittsburgh sleep quality index","volume":"16","author":"Sohn","year":"2012","journal-title":"Sleep Breath"},{"key":"10.1016\/j.sleep.2021.05.036_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3988\/jcn.2014.10.3.210","article-title":"Validation of a Korean version of the insomnia severity index","volume":"10","author":"Cho","year":"2014","journal-title":"J\u00a0Clin Neurol"},{"key":"10.1016\/j.sleep.2021.05.036_bib18","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.sleep.2010.08.001","article-title":"Loss of response during long-term treatment of restless legs syndrome: guidelines approved by the International Restless Legs Syndrome Study Group for use in clinical trials","volume":"11","author":"Garcia-Borreguero","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib19","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","article-title":"Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome","volume":"54","author":"Earley","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2021.05.036_bib20","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1093\/ageing\/23.3.200","article-title":"Iron status and restless legs syndrome in the elderly","volume":"23","author":"O'keeffe","year":"1994","journal-title":"Age Ageing"},{"key":"10.1016\/j.sleep.2021.05.036_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.sleep.2007.12.006","article-title":"A\u00a0randomized, double-blind, placebo-controlled trial of intravenous iron sucrose in restless legs syndrome","volume":"10","author":"Earley","year":"2009","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib22","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1002\/mds.22562","article-title":"A\u00a0randomized, double-blind, placebo controlled, multi-center study of intravenous iron sucrose and placebo in the treatment of restless legs syndrome","volume":"24","author":"Grote","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2021.05.036_bib23","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.sleep.2005.01.008","article-title":"Repeated IV doses of iron provides effective supplemental treatment of restless legs syndrome","volume":"6","author":"Earley","year":"2005","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125272","article-title":"Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations","volume":"10","author":"Connor","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.sleep.2021.05.036_bib25","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/mds.27040","article-title":"Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: a randomized trial","volume":"32","author":"Trenkwalder","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.sleep.2021.05.036_bib26","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0954-6820.1953.tb07042.x","article-title":"Therapy in restless legs","volume":"145","author":"Nordlander","year":"1953","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.sleep.2021.05.036_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s10048-012-0321-1","article-title":"Systems genetic analysis of the effects of iron deficiency in mouse brain","volume":"13","author":"Jellen","year":"2012","journal-title":"Neurogenetics"},{"key":"10.1016\/j.sleep.2021.05.036_bib28","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.biochi.2009.04.009","article-title":"Systems genetics analysis of iron regulation in the brain","volume":"91","author":"Jellen","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.sleep.2021.05.036_bib29","doi-asserted-by":"crossref","first-page":"R1282","DOI":"10.1152\/ajpregu.00634.2011","article-title":"Systems genetic analysis of multivariate response to iron deficiency in mice","volume":"302","author":"Yin","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.sleep.2021.05.036_bib30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0736-5748(86)90019-5","article-title":"Long-term consequence of early iron-deficiency on dopaminergic neurotransmission in rats","volume":"4","author":"Ben-Shachar","year":"1986","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.sleep.2021.05.036_bib31","first-page":"118","article-title":"Early iron deficiency alters sensorimotor development and brain monoamines in rats","volume":"137","author":"Unger","year":"2007","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.sleep.2021.05.036_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/nn.3286","article-title":"How do environments talk to genes?","volume":"16","author":"Szyf","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.sleep.2021.05.036_bib33","doi-asserted-by":"crossref","first-page":"R276","DOI":"10.1152\/ajpregu.00429.2014","article-title":"Fetal iron deficiency induces chromatin remodeling at the Bdnf locus in adult rat hippocampus","volume":"308","author":"Tran","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.sleep.2021.05.036_bib34","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1212\/WNL.0b013e318200d779","article-title":"Transient RLS during pregnancy is a risk factor for the chronic idiopathic form","volume":"75","author":"Cesnik","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.sleep.2021.05.036_bib35","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.sleep.2009.04.005","article-title":"Pregnancy accounts for most of the gender difference in prevalence of familial RLS","volume":"11","author":"Pantaleo","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.sleep.2021.05.036_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.smrv.2011.08.006","article-title":"When gender matters: restless legs syndrome. Report of the \u201cRLS and woman\u201d workshop endorsed by the European RLS Study Group","volume":"16","author":"Manconi","year":"2012","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2021.05.036_bib37","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.smrv.2014.10.009","article-title":"Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome\/Willis-Ekbom disease during pregnancy and lactation","volume":"22","author":"Picchietti","year":"2015","journal-title":"Sleep Med Rev"},{"key":"10.1016\/j.sleep.2021.05.036_bib38","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.sleep.2020.12.017","article-title":"Developing a biomarker for restless leg syndrome using genome wide DNA methylation data","volume":"78","author":"Roy","year":"2021","journal-title":"Sleep Med"}],"container-title":["Sleep Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945721003154?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1389945721003154?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T15:36:31Z","timestamp":1761406591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1389945721003154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":38,"alternative-id":["S1389945721003154"],"URL":"https:\/\/doi.org\/10.1016\/j.sleep.2021.05.036","relation":{},"ISSN":["1389-9457"],"issn-type":[{"value":"1389-9457","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia","name":"articletitle","label":"Article Title"},{"value":"Sleep Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sleep.2021.05.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}